Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

HealthLynked (HLYK) Shares Outstanding (Diluted Average) (2016 - 2025)

HealthLynked (HLYK) has disclosed Shares Outstanding (Diluted Average) for 10 consecutive years, with $2.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) changed 0.46% to $2.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.8 million, a 0.46% change, with the full-year FY2024 number at $281.5 million, up 7.09% from a year prior.
  • Shares Outstanding (Diluted Average) was $2.8 million for Q3 2025 at HealthLynked, down from $281.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $281.9 million in Q1 2025 to a low of $2.8 million in Q3 2024.
  • A 5-year average of $226.2 million and a median of $243.4 million in 2022 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): soared 86.1% in 2021, then crashed 98.92% in 2024.
  • HealthLynked's Shares Outstanding (Diluted Average) stood at $224.7 million in 2021, then increased by 8.35% to $243.4 million in 2022, then rose by 8.0% to $262.9 million in 2023, then rose by 7.09% to $281.5 million in 2024, then tumbled by 98.99% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Shares Outstanding (Diluted Average) are $2.8 million (Q3 2025), $281.9 million (Q2 2025), and $281.9 million (Q1 2025).